Regeneron Email Format

Biotechnology
10,001-25,000 employees
Tarrytown, NY, USA

Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases across a global network.

Find contacts at Regeneron

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

first.last@regeneron.com

Company Overview

Industry
Biotechnology
Founded
1988
Headquarters
Tarrytown, NY, USA
Revenue
$10B-$25B
FUNDING Stage
Public
Key Executives
Leonard S. Schleifer (Board co-Chair, President and Chief Executive Officer), Christopher Fenimore (Executive Vice President, Finance and Chief Financial Officer), Ryan Steinberger (Executive Vice President, Chief Digital & Technology Officer)

Tech Stack

Databricks

Analytics

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Regeneron?

Regeneron uses the first.last format, so Jane Smith would be jane.smith@regeneron.com.

What are Regeneron's best-known approved medicines?

Regeneron's most widely recognized medicines include Dupixent (dupilumab), approved across nine conditions such as atopic dermatitis, asthma, and COPD, and EYLEA HD (aflibercept), used to treat wet age-related macular degeneration. Libtayo (cemiplimab) serves as Regeneron's oncology flagship for skin and lung cancers.

How does Regeneron's Genetics Center support its drug discovery efforts?

The Regeneron Genetics Center, a wholly owned subsidiary, maintains a database of nearly 3 million sequenced exomes paired with de-identified health records. It uses this resource to identify high-confidence drug targets and guide clinical trial design across Regeneron's entire pipeline.

Who co-founded Regeneron and still leads the company in 2026?

Leonard S. Schleifer, MD, PhD, co-founded Regeneron in 1988 alongside George D. Yancopoulos and continues to serve as Board co-Chair, President, and Chief Executive Officer. If you need to reach his office or other Regeneron contacts, Clay can help verify and enrich those details.

Does Regeneron sponsor any science competitions for students?

Regeneron is the title sponsor of the Regeneron International Science and Engineering Fair (ISEF), the world's largest pre-college STEM competition. In 2026, more than 1,700 high school finalists from around the world competed for over $7 million in awards and scholarships.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles